US Stock MarketDetailed Quotes

CMMB Chemomab Therapeutics

Watchlist
  • 1.550
  • -0.130-7.74%
Close Feb 25 16:00 ET
  • 1.530
  • -0.020-1.29%
Post 20:01 ET
29.23MMarket Cap-1.65P/E (TTM)

Chemomab Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chemomab Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 21, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 14, 20242024/Q30.000 / 0.000--
Aug 21, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Chemomab Therapeutics Earnings Reports

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Nov 14, 2024 07:07 ET

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Oct 11, 2024 16:04 ET

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Aug 21, 2024 07:05 ET

  • Chemomab Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)

    Jul 25, 2024 08:13 ET

    • Read more

    Trending Stocks

    Market Hot Picks Market Hot Picks
    No. Symbol Price
    NVIDIA
    NVDA
    126.630
    Tesla
    TSLA
    302.800
    Super Micro Computer
    SMCI
    45.540
    4
    Palantir
    PLTR
    87.840
    5
    Hims & Hers Health
    HIMS
    39.860
    Log In for the Full List
    Unlock Now